Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000114296 | SCV000147855 | benign | not specified | 2013-10-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312020 | SCV000846034 | benign | Inborn genetic diseases | 2022-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001668223 | SCV001890459 | benign | not provided | 2019-08-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001668223 | SCV002401639 | benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490760 | SCV002796507 | benign | Nicolaides-Baraitser syndrome; Blepharophimosis-impaired intellectual development syndrome | 2022-03-30 | criteria provided, single submitter | clinical testing |